These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27025697)

  • 1. Strengthening the Tuberculosis Specimen Referral Network in Uganda: The Role of Public-Private Partnerships.
    Joloba M; Mwangi C; Alexander H; Nadunga D; Bwanga F; Modi N; Downing R; Nabasirye A; Adatu FE; Shrivastava R; Gadde R; Nkengasong JN
    J Infect Dis; 2016 Apr; 213 Suppl 2(Suppl 2):S41-6. PubMed ID: 27025697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Specimen-Referral System and Increased Access to Quality Laboratory Services in Ethiopia: The Role of the Public-Private Partnership.
    Kebede Y; Fonjungo PN; Tibesso G; Shrivastava R; Nkengasong JN; Kenyon T; Kebede A; Gadde R; Ayana G
    J Infect Dis; 2016 Apr; 213 Suppl 2(Suppl 2):S59-64. PubMed ID: 27025700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing Laboratory Quality Management Systems in Mozambique: The Becton Dickinson-US President's Emergency Plan for AIDS Relief Public-Private Partnership Initiative.
    Skaggs B; Pinto I; Masamha J; Turgeon D; Gudo ES
    J Infect Dis; 2016 Apr; 213 Suppl 2(Suppl 2):S47-52. PubMed ID: 27025698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of Public-Private Partnerships: Strengthening Laboratory Medicine Systems and Clinical Practice in Africa.
    Shrivastava R; Gadde R; Nkengasong JN
    J Infect Dis; 2016 Apr; 213 Suppl 2(Suppl 2):S35-40. PubMed ID: 27025696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda.
    Ssengooba W; Gelderbloem SJ; Mboowa G; Wajja A; Namaganda C; Musoke P; Mayanja-Kizza H; Joloba ML
    Health Res Policy Syst; 2015 Jan; 13():4. PubMed ID: 25589057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing access to the MDR-TB surveillance programme through a collaborative model in western Kenya.
    Park PH; Magut C; Gardner A; O'yiengo DO; Kamle L; Langat BK; Buziba NG; Carter EJ
    Trop Med Int Health; 2012 Mar; 17(3):374-9. PubMed ID: 22141433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tapping private health sector for public health program? Findings of a novel intervention to tackle TB in Mumbai, India.
    Shibu V; Daksha S; Rishabh C; Sunil K; Devesh G; Lal S; Jyoti S; Kiran R; Bhavin V; Amit K; Radha T; Sandeep B; Minnie K; Kaur GR; Vaishnavi J; Sudip M; Sameer K; Achutan NS; Sanjeev K; Puneet D
    Indian J Tuberc; 2020 Apr; 67(2):189-201. PubMed ID: 32553311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of tuberculosis and drug-resistant tuberculosis.
    Iseman MD; Heifets LB
    N Engl J Med; 2006 Oct; 355(15):1606-8. PubMed ID: 17035655
    [No Abstract]   [Full Text] [Related]  

  • 9. Successfully Engaging Private Providers to Improve Diagnosis, Notification, and Treatment of TB and Drug-Resistant TB: The EQUIP Public-Private Model in Chennai, India.
    Ananthakrishnan R; Richardson MD; van den Hof S; Rangaswamy R; Thiagesan R; Auguesteen S; Kamp N
    Glob Health Sci Pract; 2019 Mar; 7(1):41-53. PubMed ID: 30926737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scale-up of multidrug-resistant tuberculosis laboratory services, Peru.
    Shin SS; Yagui M; Ascencios L; Yale G; Suarez C; Quispe N; Bonilla C; Blaya J; Taylor A; Contreras C; Cegielski P
    Emerg Infect Dis; 2008 May; 14(5):701-8. PubMed ID: 18439349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of seven tests for the rapid detection of multidrug-resistant tuberculosis in Uganda.
    Bwanga F; Joloba ML; Haile M; Hoffner S
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):890-5. PubMed ID: 20550774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of public-private partnerships in achieving UNAIDS HIV treatment targets.
    Shrivastava R; Fonjungo PN; Kebede Y; Bhimaraj R; Zavahir S; Mwangi C; Gadde R; Alexander H; Riley PL; Kim A; Nkengasong JN
    BMC Health Serv Res; 2019 Jan; 19(1):46. PubMed ID: 30658625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
    Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of laboratories and laboratory systems in effective tuberculosis programmes.
    Ridderhof JC; van Deun A; Kam KM; Narayanan PR; Aziz MA
    Bull World Health Organ; 2007 May; 85(5):354-9. PubMed ID: 17639219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities.
    Drobniewski FA; Nikolayevskyy V; Hoffner S; Pogoryelova O; Manissero D; Ozin AJ
    Euro Surveill; 2008 Mar; 13(12):. PubMed ID: 18761994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A public-private partnership to reduce tuberculosis burden in Akwa Ibom State, Nigeria.
    Asuquo AE; Pokam BD; Ibeneme E; Ekpereonne E; Obot V; Asuquo PN
    Int J Mycobacteriol; 2015 Jun; 4(2):143-50. PubMed ID: 26972883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Shared Laboratory Services: Detecting Mycobacterium Tuberculosis Complex and Drug Resistance Using Molecular and Culture-Based Methods.
    Tans-Kersten J; Grace Lin SY; Desmond E; Warshauer D
    Public Health Rep; 2016; 131(1):117-25. PubMed ID: 26843677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential impacts of PEPFAR transition on private for-profit, private not-for-profit and publicly owned health facilities in Uganda.
    Wilhelm JA; Paina L; Qiu M; Zakumumpa H; Bennett S
    Health Policy Plan; 2020 Mar; 35(2):133-141. PubMed ID: 31713608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience establishing tuberculosis laboratory capacity in a developing country setting.
    Paramasivan CN; Lee E; Kao K; Mareka M; Kubendiran G; Kumar TA; Keshavjee S; Satti H; Alabi G; Raviglione M; Roscigno G
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):59-64. PubMed ID: 20003696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.